Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Marstacimab for Children with Severe Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Czechia Denmark France Germany Italy +2
  • Study on the Use of Simoctocog Alfa and Emicizumab for Surgery in Patients with Severe Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Croatia Finland France Germany Italy Spain
  • Study on the Use of Simoctocog Alfa for Women and Girls with Hemophilia A Undergoing Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland France Germany Italy Romania Spain
  • Efficacy of efanesoctocog alfa in reducing synovitis in patients with congenital hemophilia A – a multicenter, randomized, open‑label phase 3 trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany
  • Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

    Not yet recruiting

    3 1 1 1
    Bulgaria Croatia Czechia France Hungary Ireland +4
  • A study looking at the safety of switching from emicizumab to denecimig in adults and adolescents with haemophilia A with or without inhibitors

    Not recruiting

    3 1 1
    Austria Belgium France Germany Italy Spain
  • Study on Emicizumab for Patients with Mild or Moderate Hemophilia A Without FVIII Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France Germany
  • Study on Synovial Hypertrophy in Patients with Hemophilia A Using Efanesoctocog Alfa Prophylaxis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Norway Spain Sweden
  • Safety Study of Damoctocog Alfa Pegol for Children Aged 7 to 11 with Severe Hemophilia A

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Norway
  • Study on the Safety and Effectiveness of Giroctocogene Fitelparvovec for Adult Men with Moderate to Severe Hemophilia A

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Spain Sweden